Assignee
SAGE THERAPEUTICS INC
US·91 granted patents·126 pending applications·841 citations·filing 2012–2025
Top patents by PatentIndex Score
217 records- 0199US11530237B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·9 cites·4 claims
- 0299US11149057B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Oct 19, 2021·9 cites·33 claims
- 0399US10723758B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 28, 2020·20 cites·2 claims
- 0499US10246482B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 2, 2019·38 cites·85 claims
- 0598US11905309B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·5 cites·18 claims
- 0698US11878995B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 23, 2024·5 cites·16 claims
- 0798US11613556B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·6 cites·20 claims
- 0898US11542297B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Jan 3, 2023·9 cites·28 claims
- 0998US11241446B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·12 cites·15 claims
- 1098US11149054B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 19, 2021·14 cites·8 claims
- 1198US11111266B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Sep 7, 2021·15 cites·25 claims
- 1298US11104701B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Aug 31, 2021·16 cites·24 claims
- 1398US10870677B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·13 cites·1 claims
- 1498US10696712B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·21 cites·3 claims
- 1598US10259840B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2015·Granted Apr 16, 2019·30 cites·3 claims
- 1698US10227375B2Neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·33 cites·4 claims
- 1798US9512165B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·71 cites·2 claims
- 1897US12060386B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·3 cites·10 claims
- 1997US11926646B2C7 substituted oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·5 cites·11 claims
- 2097US11884697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·6 cites·27 claims
- 2197US11780875B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·4 cites·20 claims
- 2297US11732000B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Aug 22, 2023·6 cites·12 claims
- 2397US11643434B2Neuroactive steroids and compositions thereofSAGE THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·9 cites·25 claims
- 2497US11498940B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·8 cites·30 claims
- 2597US11407782B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·5 cites·22 claims
- 2697US11236121B2Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2017·Granted Feb 1, 2022·23 cites·5 claims
- 2797US10822370B219-nor neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·13 cites·24 claims
- 2897US10774108B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2015·Granted Sep 15, 2020·12 cites·18 claims
- 2997US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
- 3097US10745436B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 18, 2020·9 cites·30 claims
- 3197US10342810B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·17 cites·16 claims
- 3297US10201550B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Feb 12, 2019·23 cites·2 claims
- 3397US10172871B219-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jan 8, 2019·20 cites·12 claims
- 3497US9725481B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Aug 8, 2017·46 cites·26 claims
- 3597US9365611B219-NOR neuroactive steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·49 cites·25 claims
- 3696US12129276B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·2 cites·20 claims
- 3796US11945836B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·3 cites·20 claims
- 3896US11851457B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2021·Granted Dec 26, 2023·4 cites·18 claims
- 3996US11344563B219-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Granted May 31, 2022·8 cites·20 claims
- 4096US11279730B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 4196US11147877B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Oct 19, 2021·8 cites·12 claims
- 4296US11046728B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Granted Jun 29, 2021·8 cites·14 claims
- 4395US12268697B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·1 cites·4 claims
- 4495US12180247B2Oxysterols and methods of use thereofSAGE THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·2 cites·12 claims
- 4595US12048706B2Methods of treating epilepsy or status epilepticusSAGE THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·3 cites·4 claims
- 4695US11884696B2Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroidSAGE THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·4 cites·19 claims
- 4795US11667668B2Compositions and methods for treating CNS disordersSAGE THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·3 cites·8 claims
- 4895US11634453B2Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Apr 25, 2023·8 cites·46 claims
- 4995US11426417B2Neuroactive steroid formulations and methods of treating CNS disordersSAGE THERAPEUTICS INC·Filed 2019·Granted Aug 30, 2022·8 cites·6 claims
- 5095US10329320B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2016·Granted Jun 25, 2019·18 cites·25 claims
Showing the top 50 of 217 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →